Current Psychiatry Reports

Web alert

A new medication for the worst addiction

Charles P. O’Brien

Genetics and smoking behavior

Robert A. Schnoll, Terrance A. Johnson, Caryn Lerman

Why buprenorphine is so successful in treating opiate addiction in France

M. Fatseas, Marc Auriacombe

Targeted modulators of the endogenous cannabinoid system: Future medications to treat addiction disorders and obesity

David R. Janero, Alexandros Makriyannis

Treatment of patients comorbid for addiction and other psychiatric disorders

Kathleen T. Brady, Marcia L. Verduin, Bryan K. Tolliver

The future of vaccines in the management of addictive disorders

Frank M. Orson, Berma M. Kinsey, Rana A. K. Singh, Yan Wu, Tracie Gardner, Thomas R. Kosten

The role of stress in addiction relapse

Rajita Sinha

Sleep disturbances and ADHD medications

Anthony L. Rostain

Recent advances in structural and functional brain imaging studies of attention-deficit/hyperactivity disorder

A. M. Clare Kelly, Daniel S. Margulies, F. Xavier Castellanos

When ADHD and substance use disorders intersect: Relationship and treatment implications

Timothy E. Wilens, Steven Fusillo

Concurrent ADHD and bipolar disorder

Russell E. Scheffer

Clinical recommendations in current practice guidelines for diagnosis and treatment of ADHD in adults

Christopher Gibbins, Margaret Weiss

Current status of cognitive-behavioral therapy as a psychosocial treatment for adult attention-deficit/hyperactivity disorder

J. Russell Ramsay

ADHD genetics: 2007 update

Josephine Elia, Marcella Devoto